EC approves Janssen T-cell therapy for multiple myeloma treatment
Approval provides another step forward in transforming multiple myeloma outcomes and eliminating the disease
Read More
Tag: T-cell
Cell door: EMA grants ATMP classification to CELTIC-19
Advanced Therapy Medicinal Product classification for Ixaka Ltd’s chemically encapsulated lentiviral vector
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
